Technology innovation stands to reap billions from a warming planet.
The company may have failed, but not everything it did was a bad idea.
Cardiologist and genomic-medicine expert Eric Topol makes his case for a future of “medical selfies.”
Raising millions, Editas proved that investors are enthusiastic about gene editing. Now the company has to make its technology work.
Thirteen years after the human genome was sequenced, some remarkable treatments are being developed.
Herceptin, the original genetic drug, showed that not all cancers are alike.
His startup is using data to unlock the connections between DNA and illness.
Startups focused on Asia are among those aiming to bring precision medicine to far more people.
The average Olympics goes over budget by 156 percent. For a third of the games since 1960, nobody even knows the cost overruns.
Drones aren’t new technology by any means. Now, however, thanks to robust investments and a somewhat more relaxed regulatory environment, it appears their time has arrived—especially in agriculture.